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Over the past two decades, dengue virus serotype 3
(DENV-3) has caused unexpected epidemics of dengue
hemorrhagic fever (DHF) in Sri Lanka, East Africa, and
Latin America. We used a phylogenetic approach to evalu-
ate the roles of virus evolution and transport in the emer-
gence of these outbreaks. Isolates from these geographi-
cally distant epidemics are closely related and belong to
DENV-3, subtype III, which originated in the Indian subcon-
tinent. The emergence of DHF in Sri Lanka in 1989 corre-
lated with the appearance there of a new DENV-3, subtype
III variant. This variant likely spread from the Indian sub-
continent into Africa in the 1980s and from Africa into Latin
America in the mid-1990s. DENV-3, subtype III isolates
from mild and severe disease outbreaks formed genetical-
ly distinct groups, which suggests a role for viral genetics in
DHF.
A
rthropod-borne viruses are responsible for the emer-
gence of unexpected diseases in humans, as illustrat-
ed by the identification of West Nile virus encephalitis in
the American hemisphere in 1999 (1). The emergence of a
new disease is often attributable to the transport of a
pathogen (as in the case of West Nile virus) or changes in
the evolution or ecology of a native pathogen that hitherto
caused mild or no disease in humans (2,3). We studied
unexpected outbreaks of dengue hemorrhagic fever (DHF)
in Sri Lanka, East Africa, and Latin America caused by
dengue serotype 3 (DENV-3) virus. 
Most persons infected with dengue viruses are asymp-
tomatic or develop dengue fever (DF). DHF and dengue
shock syndrome (DSS), which can be fatal, develop in a
minority of infected persons. The pathogenesis of DHF is
poorly understood, although factors such as age and previ-
ous exposure to dengue infections increase the risk for
severe disease (4). Epidemiologic studies point to particu-
lar DENV strains being more virulent than others (5–8).
For example, the dengue genotypes endemic to Central
and South America have caused mild disease, while the
Asian genotypes introduced to the region have led to DHF
epidemics (9–16). Similarly, outbreaks of DHF in some
Pacific islands have been traced to the introduction of
Southeast Asian dengue strains (17). DENV-2 subtypes
associated with mild and severe disease epidemics have
distinct mutations in the E gene and 5′ and 3′ untranslated
segments of the viral genome, although whether these
mutations directly contribute to pathogenesis is unproven
(18). 
The distribution of DHF and DSS in Asia has been par-
ticularly puzzling. Before 1989, DHF was common in
Southeast Asia but rare in the Indian subcontinent despite
the circulation of all four serotypes in both regions. After
1989, this pattern of disease changed and regular epi-
demics of DHF were reported from several countries in the
Indian subcontinent (19). Sri Lanka, in particular, experi-
enced a dramatic and persistent increase in DHF cases
(20). Epidemiologic studies of dengue in Sri Lanka have
demonstrated that the intensity of virus transmission, as
well as the relative abundance of each serotype, remained
constant before and after the emergence of DHF (21).
Thus, DHF did not emerge in Sri Lanka because of an
overall increase in virus transmission or shift in serotype. 
Although all four serotypes of dengue circulate in Sri
Lanka, persons who have the severe form of the disease
are most frequently infected with DENV-3 (20,22).
Lanciotti et al. characterized the genetic relatedness of
DENV-3 isolates from regions throughout the tropics and
subtropics and identified four geographically distinct sub-
types (23). All Sri Lankan isolates were classified as sub-
type III, which also includes isolates from East Africa and
India, as well as recent isolates from Latin America.
Because DENV-3 isolates from Sri Lanka isolated before
and after 1989 (when DHF emerged) formed separate
groups within subtype III, Lanciotti and colleagues postu-
lated that a genetic shift in DENV-3 may have been
responsible for the emergence of DHF (23). 
In the current study, using phylogenetic methods, we
analyzed DENV-3 viruses isolated from Sri Lanka for up
to 10 years after the emergence of DHF to confirm the
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USA; and §Medical Research Institute, Colombo, Sri Lankaestablishment of a new genotype and evaluate the roles of
virus evolution and transport in establishing a new geno-
type. DENV-3, subtype III was introduced into Latin
America in 1994 (11), and the virus has subsequently been
isolated from DF and DHF outbreaks throughout Central
and South America (12–16). We also examined the genet-
ic relationships between DENV-3, subtype III isolates
from Latin America, East Africa, and the Indian subconti-
nent. On the basis of our results, we describe the most
likely scenario of events that led to the emergence of
DENV-3 –associated DHF in the Indian subcontinent and
the Americas. 
Materials and Methods
Virus Strains 
The dengue virus strains sequenced for this study as
well as sequences obtained from GenBank for this study
are listed in Table 1. The virus isolates were obtained
from the Centers for Disease Control and Prevention,
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Table 1. Dengue virus type 3 sequences used
a 
Strain  Y  Location  Name  Subtype  Sequence source  GenBank accession no. 
D1266  1983  Sri Lanka  83SriLan1  III  This study  AF547225 
D1306  1983  Sri Lanka  83SriLan2  III  This study  AF547226 
D1307  1983  Sri Lanka  83SriLan3  III  This study  AF547227 
D1336  1983  Sri Lanka  83SriLan4  III  This study  AF547228 
D1440  1984  Sri Lanka  84SriLan1  III  This study  AF547229 
073  1985  Sri Lanka  85SriLan  III  This study  AF547241 
D2783  1989  Sri Lanka  89SriLan1  III  This study  AF547230 
D2863  1989  Sri Lanka  89SriLan2  III  This study  AF547231 
D2803  1989  Sri Lanka  89SriLan3  III  This study  AF547232 
D3197  1990  Sri Lanka  90SriLan1  III  This study  AF547233 
D5231  1993  Sri Lanka  93SriLan1  III  This study  AF547234 
D9397  1994  Sri Lanka  94SriLan1  III  This study  AF547235 
L57  1997  Sri Lanka  97SriLan1  III  This study  AF547242 
K1  1998  Sri Lanka  98SriLan  III  This study  AF547243 
1557  1985  Mozambique  85Mozamb1  III  This study  AF547236 
1558  1985  Mozambique  85Mozamb2  III  This study  AF547237 
1559  1985  Mozambique  85Mozamb3  III  This study  AF547238 
251991  1991  Kenya  91Kenya  III  This study  AF547239 
SOM079  1993  Somalia  93Somalia  III  This study  AF547240 
32267  1994  Nicaragua  94Nicara1  III  This study  AF547244 
6845  1998  Nicaragua  98Nicara1  III  This study  AF547245 
7431  1998  Nicaragua  98Nicara2  III  This study  AF547246 
7071  1998  Nicaragua  98Nicara3  III  This study  AF547262 
BC 96/94  1994  Panama  94Panama1  III  This study  AF547247 
032231  1994  Panama  94Panama2  III  This study  AF547248 
BC 13/96  1994  Panama  94Panama3  III  This study  AF547249 
BC 20/97  1996  Mexico  96Mexico1  III  This study  AF547250 
BC 172/97  1996  Mexico  96Mexico2  III  This study  AF547251 
BC 184/97  1996  Mexico  96Mexico3  III  This study  AF547252 
BC173/97  1996  Mexico  96Mexico4  III  This study  AF547253 
17605  1995  Costa Rica  95CostaR1  III  This study  AF547254 
17608  1995  Costa Rica  95CostaR2  III  This study  AF547255 
322473  1995  Costa Rica  95CostaR3  III  This study  AF547256 
322488  1995  Costa Rica  95CostaR4  III  This study  AF547257 
20/8  1997  Guatemala  97Guatem1  III  This study  AF547263 
366-781  1998  Puerto Rico  98PuertoR1  III  This study  AF547258 
400-996  2000  Puerto Rico  00PuertoR1  III  This study  AF547264 
MK  1998  El Salvador  98ElSalv1  III  This study  AF547259 
612210  2001  Venezuela  01Venezue1  III  This study  AF547260 
VEN03  2001  Venezuela  01VEN03  III  This study  AF547261 
Ref. 18  1981–91  Sri Lanka  81,85,89,91 SriLanA  III  GenBank  L11431,L11436–L11438 
Ref. 18  1984  India  84IndiaA  III  GenBank  L11424 
Ref. 18  1986  Samoa  86Samoa  III  GenBank  L11435 
Ref. 18  1962–86  Thailand  62,73,86,86 Thailand  II  GenBank  L11440–L11442,L11620 
Ref. 18  1983  Philippines  83Philipp  I  GenBank  L11432 
Ref. 18  1989  Tahiti  89Tahiti  I  GenBank  L111619 
Ref. 18  1992  Fiji  92Fiji  I  GenBank  L11422 
Ref. 18  1973–85  Indonesia  73,78,85 Indones  I  GenBank  L11425,L11426,L11428 
Ref. 18  1974–81  Malaysia  74,81 Malaysi  I  GenBank  L11429,L11427 
Ref. 18  1956  Philippines  D3H-87  I  GenBank  L11423 
Ref. 18  1963–77  Puerto Rico  63,77 PuertoR  IV  GenBank  L11433,L11434 
Ref. 18  1965  Tahiti  65 Tahiti  IV  GenBank  L11439 
aIncludes original identifier for strain, year of isolation, taxa name used in this paper, dengue virus 3 subtype, source of viral sequence, and GenBank accession numbers. Dengue Branch, Puerto Rico, and Division of Vector-
Borne Infectious Diseases, Ft. Collins, Colorado;
Medical Research Institute, Colombo, Sri Lanka; School
of Public Health, Berkeley, California; Walter Reed
Army Institute for Research, Washington, D.C.; and
University of Massachusetts Medical Center, Worcester,
Massachusetts.
RNA Extraction
QiaAmp Viral RNAMini Kit (QIAGEN, Valencia, CA)
was used to extract viral RNA from both the mosquito
grind supernatants and infected tissue culture media fol-
lowing the manufacturer’s protocol. Extracted RNA was
stored at –70°C or immediately subjected to reverse tran-
scription–polymerase chain reaction (RT-PCR). 
RT-PCR
DENV-3 RT-PCR was carried out as described by
Lanciotti (23). Primers were designed to amplify and
sequence a 966-bp fragment from positions 179–1,144,
encompassing part of Capsid, all of PreM, and part of the
E gene sequences. The reverse primer (DEN3/735)
hybridized to positions 1,189–1,171 (5′-ctcctcaggcaaaac-
cgct-3′) and the forward primer (D1 consensus) hybridized
to positions 132–159 (5′-tcaatatgctgaaacgcgcgagaaaccg-
3′). The reverse primer DEN3/735 was added to extracted
RNA, incubated at 85°C for 90 s, and allowed to cool to
room temperature. RT was carried out for 45–60 min in 20
µL of reaction mix containing 25 U avian myeloblastosis
virus reverse transcriptase (Roche, Nutley, NJ), deoxynu-
cleoside tripophosphate, MgCl2, and RT buffer. PCR was
performed by adding a 30-µL cocktail containing D1 con-
sensus primer, PCR buffer, and EXPAND polymerase
(Roche) to the 20-µL RT reaction. PCR conditions were 4
min at 94°C, 30–35 cycles of 94°C for 30 s, 54°C for 30 s,
and 72°C for 90 s with 5 s/cycle added to elongation step
after the first 10 cycles. We separated 5 µL of the reaction
products on 2% agarose gels and visualized it by ethidium
bromide staining. When necessary, target bands were
excised and purified by using the Qiagen QIAquick Gel
Extraction kit (QIAGEN) following manufacturer’s
instructions. All remaining PCR reaction products were
purified by using the Qiagen PCR Purification kit follow-
ing the manufacturer’s protocol. 
DNA Sequencing
Purified PCR products were sent to the automated DNA
sequencing facility at the University of North Carolina,
Chapel Hill, NC. The DENV-3 sequences used in this man-
uscript included 40 newly determined sequences, which
have been submitted to GenBank (accession nos.
AF547225–AF547264).
Viral Sequence Analysis
Overlapping individual nucleic acid sequences were
assembled with the aid of VECTOR NTI ContigExpress
(InforMax, Inc., Bethesda, MD). Sequences were aligned
and analyzed by using the following software: Clustal X
(available from: URL: http://inn-prot.weizmann.ac.il/soft-
ware/ClustalX.html), PAUP* (available from: URL:
http://www.sinauer.com), PHYLIP (available from: URL:
http://evolution.genetics.washington.edu/phylip.html), and
MEGA II (available from: URL: http://www.megasoft-
ware.net). Genetic distances were calculated by using
Tamura-Nei distance algorithm with 1,000 bootstrap repli-
cates; the trees were generated by using the Minimum
Evolution method. The phylogenetic tree in Figure 1 is
based on a 708-base segment, positions 437–1,145, span-
ning pre-M/M and a portion of the E gene. The phyloge-
netic tree presented in Figure 2 is based on 966-base region
spanning positions 179–1,145 on the viral genome, captur-
ing a portion of the C gene, all of pre-M/M gene, and a
portion of the E gene.
Results and Discussion
Many investigators have used viral nucleotide sequence
data and phylogenetic methods to understand genetic rela-
tionships between viruses, as well as the epidemiology of
viral disease. Phylogenetic studies have shown that dengue
viruses can move long distances between continents (24)
as well as short distances between neighboring countries
(25). Our goal was to use a phylogenetic approach to
understand recent DHF outbreaks caused by DENV-3
infections in the Indian subcontinent and Latin America. 
Previous phylogenetic analysis of DENV-3 has princi-
pally relied on complete or partial sequences of the pre-
M/M and E genes (13,16,17,23). Our analysis used a 708-
base segment, positions 437–1,145, spanning pre-M/M
and a portion of the E gene, coding for 236 amino acids.
This region was selected because it both conserved the
original phylogenetic relationship identified by Lanciotti
et al. and, in preliminary analysis with previously estab-
lished sequences, captured 44% of the variable sites with-
in DENV-3, subtype III Sri Lankan sequences. No inser-
tion/deletion mutations and no hypervariable regions were
detected in this span. 
A total of 40 DENV-3 sequences, including 21
sequences available from GenBank and 19 newly deter-
mined Indian subcontinent and African sequences (Table
1) were compared. Dates of isolation ranged from 1963 to
1998. With the exception of 63PuertoR, all sequences
were from low-passage (<4) virus cultures. Several
approaches to phylogenetic analysis, including maximum
likelihood, parsimony, and distance methods, were com-
pared. All approaches yielded identical or nearly identical
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algorithm to calculate genetic distances and the minimum
evolution method to create the trees (Figure 1). The tree
identifies four distinct lineages that correspond to the
region of isolation, reproducing the same evolutionary
relationship first described by Lanciotti, et al. (23).
Subtype I includes isolates from Southeast Asia and the
South Pacific islands; subtype II consists of isolates from
Thailand; subtype III is comprised of isolates from the
Indian subcontinent, East Africa, and a single isolate from
Samoa; and subtype IV includes Puerto Rico and Tahiti.
Similarity within subtypes was high, with subtype III
showing the greatest mean similarity (98.4%), followed
by subtypes I, II, and IV (Table 4). 
All 24 Sri Lankan, Indian, and East African strains fell
into subtype III (Figure 1). The circulating virus genotypes
within this region have remained closely related over the
relatively long period of 18 years (1981–1998), indicating
that countries bordering the western Indian Ocean form a
geographically distinct region with regard to DENV-3
viruses. DENV-2 viruses in the regions also form a subtype
with a similar geographic distribution (26,27). Frequent
trade between East Africa, Western Indian Ocean islands,
and the Indian subcontinent may have been responsible for
the movement of dengue viruses throughout the region
(26,28). Rico-Hesse, for example, demonstrated the intro-
duction of DENV-2 to Africa from islands in the Indian
Ocean (26). The earliest subtype III virus on record is an
isolate from India in 1966; this virus occupies a node that
is ancestral to all the subsequent Asian and African isolates
(R.S. Lanciotti, pers. comm.), suggesting that the DENV-
3, subtype III viruses have their origin in the Indian sub-
continent and have subsequently spread out of the region.
In Sri Lanka, regular epidemics of DHF have been
observed only after 1988. DENV-3 is responsible for many
of the infections that progress to DHF (20,22). DENV-3
isolates obtained before and after the emergence of DHF
are very closely related and belong to subtype III, indicat-
ing that the emergence of DHF on the island is not due to
the introduction of a new subtype from outside the region.
However, within subtype III, most Sri Lankan isolates
(except for 93SriLan1) from before and after the emer-
gence of DHF segregated into two distinct clades, desig-
nated groups A and B (Figure 1). Group A, with nine iso-
lates from 1981 to 1989, consists of viruses collected up to
the year epidemic DHF emerged in Sri Lanka but contains
no isolates from later than 1989. Group B includes eight
isolates from 1989 to 1998 but none from before 1989.
Emerging Infectious Diseases • Vol. 9, No. 7, July 2003 803
RESEARCH
Figure 1. Phylogenetic tree of estab-
lished dengue virus 3 (DENV-3) sub-
types (23) and the relationship of Sri
Lanka pre– and post–dengue hemor-
rhagic fever DENV-3 isolates to the
established subtypes. This tree is based
on a 708-base segment, positions 437
to 1145, spanning pre-M/M and a por-
tion of the E gene. Scale bar shows
number of substitutions per bases
weighted by Tamura-Nei algorithm.
Horizontal distances are equivalent to
the distances between isolates.
Numbers at nodes indicate bootstrap
support values for the branch of the tree
inferred at that node. The origin of the
viruses and sequences used are listed
in Table 1. The amino acid substitutions
conserved within each DENV-3 subtype
are listed in Table 2. DHF, dengue hem-
orrhagic fever.Temporally, the two groups are continuous, by virtue of
sharing isolates in 1989. Group A includes isolate
89SriLan2, while group B contains 89SriLan1, 89SriLan3,
and 89SriLanA. However, the groups do not form a contin-
uous lineage; they share a common ancestor only at the
node for subtype III (Figure 1). Group B shares ancestral
nodes with isolates from India and East Africa. Because
the Indian and East African isolates overlap temporally
with group A(all isolates are from the 1980s), group Aand
group B lineages likely diverged sometime before 1981
and followed distinct evolutionary pathways. 
We propose two likely scenarios that led to the emer-
gence of group B viruses in Sri Lanka. One possibility is
that the group B viruses were introduced from India or
East Africa into Sri Lanka because Indian and East African
isolates from the mid-1980s are closely related to Sri
Lankan group B viruses (Figure 1). Of the two regions,
India is the more likely source because of geographic prox-
imity to Sri Lanka, although the East African viruses could
be the direct ancestors of the group B viruses. Another pos-
sibility is that both groups co-circulated in Sri Lanka in the
early 1980s, with group B being a minor population. Some
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Table 2. Amino acid substitutions conserved within each dengue virus 3 subtype for the isolates used to create the phylogenetic tree in 
Figure 1
a 
Position 
Subtype  Name  31  55  57  128  135  148  188  234 
Outgroup  56Philipp  I  H  T  L  I  L  D  I 
I  73Indones  –  L  –  F  –  –  –  V 
I  74Malaysi  –  L  –  F  –  –  –  V 
I  78Indones  –  L  –  F  –  –  –  V 
I  81Malaysi  –  L  –  F  –  –  –  V 
I  83Philipp  –  L  –  F  –  –  –  V 
I  85Indones  –  L  –  F  –  –  –  V 
I  89Tahiti  –  L  –  F  –  –  –  V 
I  92Fiji  –  L  –  F  –  –  –  V 
II  62Thailan  –  –  A  –  –  W  –  – 
II  73Thailan  –  –  A  –  –  –  –  – 
II  86Thailan  –  L  A  –  –  –  –  – 
II  87Thailan  –  L  A  –  –  –  –  – 
III  85Mozamb1  –  –  –  –  –  –  –  – 
III  85Mozamb2  –  –  –  –  –  –  –  – 
III  85Mozamb3  –  –  –  –  –  –  –  – 
III  84IndiaA  –  –  –  –  –  –  –  – 
III  91Kenya  –  –  –  –  –  –  –  – 
III  93Somolio  –  –  –  –  –  –  –  – 
III  81SriLanA  –  –  –  –  –  –  –  – 
III  83SriLan1  –  –  –  –  –  –  –  – 
III  83SriLan2  –  –  –  –  –  –  –  – 
III  83SriLan3  –  –  –  –  –  –  –  – 
III  83SriLan4  –  –  –  –  –  –  –  – 
III  84SriLan1  –  –  –  –  –  –  –  – 
III  85SriLanA  –  –  –  –  –  –  –  – 
III  85SriLan  –  –  –  –  –  –  –  – 
III  89SriLan2  –  –  –  –  –  –  –  – 
III  89SriLanA  –  –  –  –  –  –  –  – 
III  89SriLan1  –  –  –  –  –  –  –  – 
III  89SriLan3  –  –  –  –  –  –  –  – 
III  90SriLan1  –  –  –  –  –  –  –  – 
III  91SriLanA  –  –  –  –  –  –  –  – 
III  93SriLan1  –  –  –  –  –  –  –  – 
III  94SriLan1  –  –  –  –  –  –  –  – 
III  97SriLan1  –  –  –  –  –  –  –  – 
III  98SriLan1  –  –  –  –  –  –  –  – 
III  86Samoa  –  –  –  –  –  –  –  – 
IV  63PuertoR  T  –  –  F  L  M  E  – 
IV  65Tahiti  T  –  –  F  L  M  E  – 
IV   77PuertoR  T  –  –  F  L  M  E  – 
aReference strain 56Philipp is the highly passaged laboratory strain H87. Positions are numbered sequentially from the first position in the pre-M/M protein selective force operating in the late 1980s may have shift-
ed the balance in favor of group B viruses. In either case,
group B viruses emerged in Sri Lanka because a subtype
III variant already established in the greater region became
more common in Sri Lanka and not because a novel virus
evolved and emerged de novo on the island. 
DENV-3, subtype III was detected in the Americas dur-
ing DF and DHF outbreaks in Nicaragua and Panama in
1994 (11). Subsequently, the virus has spread to many
countries in Latin America, and DENV-3–associated DHF
was confirmed in several countries (13,14,16,29–31)
(Figure 3). To establish the relationship of recent Latin
American DENV-3 isolates to each other and to the previ-
ously identified Indian subcontinent and East African sub-
type III isolates, we sequenced and analyzed a 966-base
region spanning positions 179–1,145 on the viral genome,
capturing a portion of the C gene, all of pre-M/M gene, and
a portion of the E gene. This region adds 288 positions to
the 5′ end of the sequences initially presented in this study. 
Forty-three isolates were sequenced (21 from Mexico
and Central and South America, 16 from Sri Lanka, 1 from
India, and 5 from East Africa) (Table 1). The D3H-87
belonging to DENV-3, subtype 1 was used as an outgroup.
Years of isolation ranged from 1983 to 2001, an 18-year
span. Except for the D3H-87 outgroup, all other isolates
were low-passage clinical isolates. Most of the nucleotide
mutations were silent: only 12 amino acid positions
showed any variability and only 2 positions showed vari-
ability in more than one isolate. Consequently, the evolu-
tionary relationships observed in this analysis likely reflect
the results of genetic drift and are unlikely to have been
influenced by host-specific selection events on this portion
of the genome (26). 
All sequences included in this analysis fell within sub-
type III (data not shown). Several approaches to phyloge-
netic analysis were compared, and all approaches yielded
identical or nearly identical topologies. We used the
Tamura-Nei algorithm to calculate genetic distances and
the minimum evolution method to create the trees (Figure
2). Bootstrap values are shown at critical nodes. Despite
the high overall similarity of the isolates in this analysis,
geographically and temporally distinct groups formed sep-
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Figure 2. Phylogenetic tree of dengue
virus 3, subtype III group A, group B, East
Africa, and Latin America. Tree is based
on 966-base region spanning positions
179–1,145 on the viral genome, capturing
a portion of the C gene, all of pre-M/M
gene and a portion of the E gene.
Nucleotide substitutions conserved within
each dengue virus 3, subtype III group
(group A, B, East Africa, and Latin
America) are listed in Table 3. DHF,
dengue hemorrhagic fever.arate lineages. Generally, two separate lineages formed
within subtype III. The first consists of group A viruses
isolated from 1981 to 1989 in Sri Lanka. These viruses
have been associated only with DF. The second is com-
posed of Sri Lankan group B, Indian, East African, and all
of the isolates from Mexico and Central and South
America. 
Within group A, members are closely related, with a
nucleotide mean similarity of 99.4% (Table 5). Within the
expanded group B and related viruses, three distinct clades
exist: a group of closely related Sri Lankan isolates from
1989 to 1998, 5 East African isolates from 1985 to 1993,
and 21 isolates from 1994 to 2001 from Latin America.
Isolates 84India and 93SriLan1 are less closely related to
the other geographically distinct isolates in the larger sec-
ond lineage. 
The isolates from Latin America all emerge from a
common node on the tree, suggesting a single introduction
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Table 3. Nucleotide substitutions conserved within dengue virus 3, subtype III groups  
Position 
Group  Strain  338  429  503  566  653  686  695  707  728  734  749  791  821  866  896  902  978  1010 1019 1056 
Reference  H87  A  A  C  G  G  T  T  G  C  C  C  A  T  C  T  T  C  C  T  C 
Group A  83SriLan1  -  G  T  A  -  -  C  -  -  T  T  -  -  T  C  C  T  T  -  - 
Group A  83SriLan2  -  G  T  A  -  -  C  -  -  T  T  -  -  T  C  C  T  T  -  - 
Group A  83SriLan3  -  G  T  A  -  -  C  -  -  -  T  -  -  T  -  C  -  T  -  - 
Group A  83SriLan4  -  G  T  A  -  -  C  -  -  T  T  -  -  T  C  C  T  T  -  - 
Group A  84SriLan1  -  G  -  -  -  -  -  -  -  -  T  -  -  -  C  -  -  -  -  - 
Group A  85SriLan1  -  G  T  A  -  -  C  -  -  T  T  -  -  T  C  C  T  T  -  - 
Group A  89SriLan2  -  G  T  A  -  -  C  -  -  T  T  -  -  T  C  C  T  T  -  - 
unclassified  84India  G  G  -  -  A  -  -  -  -  -  T  -  -  -  -  -  -  -  G  - 
unclassified  93SriLan1  G  G  -  -  A  -  -  -  -  -  -  -  -  -  -  -  -  -  G  - 
East Africa  85Mozamb1  G  -  -  -  A  -  -  -  -  -  -  -  -  -  -  -  -  -  G  - 
East Africa  85Mozamb2  G  -  -  -  A  -  -  -  -  -  -  -  -  -  -  -  -  -  G  - 
East Africa  85Mozamb3  G  -  -  -  A  -  -  -  -  -  -  -  -  -  -  -  -  -  G  - 
East Africa  91Kenya  G  -  -  -  A  -  -  -  -  -  -  -  -  -  -  -  -  -  G  - 
East Africa  93Somalia  G  -  -  -  A  -  -  -  -  -  -  -  -  -  -  -  -  -  G   
Group B  89SriLan1  G  G  -  -  A  -  -  A  T  -  -  -  C  -  -  -  -  -  G  - 
Group B  89SriLan3  -  G  -  -  A  -  -  A  T  -  -  -  C  -  -  -  -  -  G  - 
Group B  90SriLan1  G  G  -  -  A  -  -  A  T  -  -  -  C  -  -  C  -  -  G  - 
Group B  94SriLan1  -  G  -  -  A  -  -  A  T  -  -  -  C  -  -  -  -  -  G  - 
Group B  97SriLan1  G  G  -  -  A  -  -  A  T  T  -  -  C  -  C  -  -  -  G  - 
Group B  98SriLan1  G  G  -  -  A  -  -  A  T  -  -  -  C  -  C  -  -  -  G  - 
L. America  94Nicara1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  94Panama1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  94Panama2  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  94Panama3  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  CostaRica1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  CostaRica2  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  CostaRica3  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  CostaRica4  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  96Mexico1  G  G  -  -  A  C  C  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  96Mexico2  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  96Mexico3  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  96Mexico4  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  97Guatem1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  98Nicara1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  98Nicara2  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  98Nicara3  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  98ElSalv1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  01Venezue1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  01VEN03  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  98PuertoR1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
L. America  00PuertoR1  G  G  -  -  A  C  -  -  -  -  -  G  C  -  -  -  -  -  G  T 
aReference strain is the highly passaged laboratory strain H87. Positions are numbered sequentially from the first nucleotide position at the 5′ end of the genome. of a virus and the subsequent diversification of the virus
population from the founding strain. The DENV-3, sub-
type III isolates from Nicaragua, Panama, and Costa Rica
are closest to the Latin American group’s originating node,
with the more recent isolates found farther from that node,
reflecting the viral population’s ongoing evolution after
the point source introduction. 
The internal branch from the Latin American group
shares a common node with the isolates from East Africa.
The common hypothetical ancestor for Latin America and
East Africa then shares a common node with the Sri
Lankan group B virus isolates. Both on the phylogenetic
tree and in pair-wise comparisons (Table 5), the Latin
American group was more closely related to the isolates
from East Africa than to the group B Sri Lankan isolates.
Furthermore, the East African isolates pre-date the earliest
Latin American isolates by 9 years, while the less closely
related Sri Lankan group B isolates are nearly contempo-
raneous with the Latin American isolates. Therefore, the
point source DENV-3 introduction into Latin America is
most likely to have its origins in East Africa and not the
Indian subcontinent (Figure 4). 
Little is known about dengue activity in Africa, partic-
ularly DENV-3 (32). DENV-3 was first detected on the
African continent in 1984 to 1985 during an outbreak in
Mozambique (32). Later studies of U.S. troops in Africa
and the Persian Gulf suggested that DENV-3 is endemic in
those regions but largely undetected (33). Our results show
that all East African DENV-3 isolates belong to subtype
III. The fact that DENV-3 was only first isolated from East
Africa in 1985, whereas the viruses were present in the
Indian subcontinent at least as far back as 1966 (R.S.
Lanciotti, pers. comm.), suggests that DENV-3, subtype III
was introduced from the Indian subcontinent into East
Africa in or before 1984 (Figure 4). This introduction led
to the establishment of a stable East African group of
DENV-3, subtype III because all the isolates from
Mozambique, Kenya, and Somalia isolated from 1985 to
1993 form a distinct clade within subtype III (Figure 3). 
The DENV-3, subtype III viruses introduced into Latin
America are most closely related to subtype III viruses in
East Africa (Figure 3). Although we can only speculate
about the exact mode of transport of DENV-3 into Latin
America, we propose that Panama, with its canal that
attracts goods as well as civilians and military personnel
from other parts of the world, may have been the point of
introduction of subtype III into the Americas. Similarly,
the introduction of DENV-2 in 1981 into Cuba may be
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Table 4. Summary of within- and between-subtype nucleotide 
mean similarity for dengue virus 3 isolates shown in Figure 1
a 
Between subtype similarity (%) 
Subtype 
Within subtype 
similarity (%)  I  II  III 
I  98.1       
II  97.7  94.9     
III  98.4  95.6  96.3   
IV  97.6  92.3  92.5  92.7 
aMean similarities were calculated with the Tamura-Nei distance algorithm. 
Figure 3. Map of the spread of dengue virus 3 (DENV-3), subtype
III through Latin America and the Caribbean. The introduction of
DENV-3, subtype III was first reported in November 1994 in
Nicaragua and Panama. This virus strain has been isolated, iden-
tified, and reported in at least 16 other countries in the region.
*Represents countries with dengue hemorrhagic fever (DHF)
caused by DENV-3. These countries are Nicaragua in 1994 and
1998, Brazil and Venezuela in 2001 (Pan American Health
Organization, unpub. data). 
Table 5. Summary of within- and between-group nucleotide mean similarity for the dengue virus 3, subtype III virus isolates shown in 
Figure 2
a 
Between group similarity 
Subgroup  Within-group similarity  Subgroup A  East Africa  Subgroup B 
Subgroup A  99.4%       
East Africa  99.5%  98.2%     
Subgroup B  98.8%  97.9%  98.7%   
Latin America  99.5%  98.0%  99.0%  98.5% 
aMean similarities were calculated with the Tamura-Nei distance algorithm. attributable to Cuban military personnel traveling between
Southeast Asia and Cuba (24,34). 
Epidemiologic and clinical studies on dengue in
Indonesia in the 1970s pointed to strain differences
between DENV-3 viruses contributing to transmission and
disease severity (35,36). Despite their overall similarity at
the nucleotide level, the DENV-3, subtype III isolates
examined in this study have been associated with severe or
mild disease outbreaks (Figure 3). Sri Lankan group A
viruses were isolated during a time of little to no DHF,
while group B viruses were isolated after the emergence of
DHF in Sri Lanka. The emergence of DHF in Sri Lanka
was not accompanied by a change in dengue transmission
or the abundance of any particular serotype (21).
Implicating DENV-3 directly as the cause of DHF in Sri
Lanka has been difficult because few virus isolates are
available from DHF patients in Sri Lanka. However, dur-
ing dengue surveillance studies in 1997, only DENV-3 was
isolated from hospitalized dengue cases, whereas DENV-
1, DENV-2, and DENV-3 were isolated from patients vis-
iting outpatient clinics (22). These observations suggest
that DENV-3 is responsible for severe dengue disease in
Sri Lanka. Further studies are required to better establish
the relative contribution of DENV-3 to severe disease in
Sri Lanka. 
The current studies support a viral genetic basis for
severe and mild disease outbreaks. We found that the popu-
lation of DENV-3 viruses associated with DHF in Sri Lanka
did not appear to be direct descendants of the group Avirus-
es that were circulating before DHF emerged in that coun-
try. The Sri Lankan 1989–1997 isolates are more closely
related to the isolates from East Africa and the isolates from
the Americas than they are to the isolates from 1981 to 1989
in Sri Lanka (Figure 3). All three groups of subtype III
viruses (Sri Lankan group B, East African group, and Latin
American group) associated with DHF are more closely
related to each other than they are to the pre–DHF group A
viruses from Sri Lanka (Figure 3). Thus, all the viruses
within subtype III are closely related (mean 98.4% identity
at the nucleotide level), yet they form distinct phylogenetic
groups associated with mild or severe disease. 
The Sri Lankan group B viruses may be associated with
severe disease unlike group A viruses because the group B
viruses are inherently more virulent. Alternatively, the
ability of preexisting dengue antibody to neutralize group
Aviruses and enhance group B viruses may account for the
observed associations with severe and mild disease. In a
recent study, antibodies against American DENV-1 viruses
neutralized the Native American DENV-2 genotype better
than the Southeast Asian DENV-2 genotype that is current-
ly circulating in the Americas and causing DHF (37). This
study lends support to the idea that Asian DENV-2 may
produce a more severe disease not because of inherent vir-
ulence properties but because persons with previous pri-
mary DENV-1 infections may enhance infection with this
genotype and neutralize infections with the Native
American DENV-2 genotype. Similarly, DENV-2 and -3
are the common serotypes in Sri Lanka, and persons with
previous primary DENV-2 infections could neutralize the
DENV-3 group A viruses better than the group B viruses.
This difference may explain the unexpected emergence of
DHF associated with group B. Further comparative studies
with group A and B viruses are needed to understand their
association with mild and severe disease, respectively. 
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Figure 4. Global spread of dengue virus 3 (DENV-3), subtype III,
which has been continuously circulating in the Indian subcontinent
from the 1960s to the present. The virus was first isolated from
East Africa in 1985 in Mozambique and subsequently from Kenya
(1991) and Somalia (1993) (32,33). DENV-3 subtype III was first
detected in the American continent in 1994 (Nicaragua and
Panama) and the virus has subsequently spread through most of
Latin America (13,14, 16,29,30). The arrows depict the most likely
directions of spread based on the phylogenetic relationships
between the viruses (see text for details). The map also displays
countries in which dengue is known to occur.References
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